Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001411920-10-000003
Filing Date
2010-06-11
Accepted
2010-06-11 17:00:30
Documents
1
Effectiveness Date
2010-06-11
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10817
  Complete submission text file 0001411920-10-000003.txt   12369
Mailing Address 140 W 57th St SUITE 9C New York NY 10019
Business Address 140 W 57th St SUITE 9C New York NY 10019 212-582-1199
IRX Therapeutics, Inc. (Filer) CIK: 0001411920 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-143398 | Film No.: 10893038